KWM
VRTX icon

Koa Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Koa Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
2,647
+179
+7% +$79.3K 0.89% 33
2026
Q1 		$1.1M Sell
2,468
-115
-4% -$53.6K 0.8% 34
2025
Q4 		$1.17M Sell
2,583
-11
-0.4% -$4.74K 0.8% 32
2025
Q3 		$1.02M Buy
2,594
+414
+19% +$173K 0.75% 34
2025
Q2 		$971K Buy
2,180
+108
+5% +$49.8K 0.77% 35
2025
Q1 		$1M Buy
+2,072
New +$966K 0.81% 33

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Koa Wealth Management's VRTX Position: Q2 2026 in Review

Koa Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 7.3% in Q2 2026, buying an estimated $79.3K and bringing the position to 2,647 shares worth $1.31M. The position accounts for 0.89% of the portfolio, ranked #33.

Koa Wealth Management first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 327 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Koa Wealth Management held 2,647 shares of Vertex Pharmaceuticals worth $1.31M as of Q2 2026.
  • Koa Wealth Management bought 179 Vertex Pharmaceuticals shares in Q2 2026, an estimated $79.3K.
  • Vertex Pharmaceuticals made up 0.89% of Koa Wealth Management's portfolio in Q2 2026, its #33 holding.
  • Koa Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 327 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Koa Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.